1. Bian, Li-Hua, Yao, Zi-Wei, Wang, Zhe-Yi, Shi, Jin-Li, Guo, Jian-You. 2022. Nardosinone regulates the slc38a2 gene to alleviate Parkinson's symptoms in rats through the GABAergic synaptic and cAMP pathways. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 153, 113269. doi:10.1016/j.biopha.2022.113269. https://pubmed.ncbi.nlm.nih.gov/35728354/
2. Du, Chunxiu, Xu, Hu, Cao, Cong, Guan, Youfei, Zhang, Xiaoyan. 2023. Neutral amino acid transporter SLC38A2 protects renal medulla from hyperosmolarity-induced ferroptosis. In eLife, 12, . doi:10.7554/eLife.80647. https://pubmed.ncbi.nlm.nih.gov/36722887/
3. Huang, Hongling, Zhou, Peipei, Wei, Jun, Yu, Jiyang, Chi, Hongbo. 2021. In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions. In Cell, 184, 1245-1261.e21. doi:10.1016/j.cell.2021.02.021. https://pubmed.ncbi.nlm.nih.gov/33636132/
4. Vaughan, Owen R, Maksym, Katarzyna, Silva, Elena, Powell, Theresa L, Jansson, Thomas. . Placenta-specific Slc38a2/SNAT2 knockdown causes fetal growth restriction in mice. In Clinical science (London, England : 1979), 135, 2049-2066. doi:10.1042/CS20210575. https://pubmed.ncbi.nlm.nih.gov/34406367/
5. Xia, Mingzhi, Chen, Jie, Hu, Yingyun, Bu, Qianqian, Shen, Haoming. 2024. miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2. In Cancer biology & therapy, 25, 2315651. doi:10.1080/15384047.2024.2315651. https://pubmed.ncbi.nlm.nih.gov/38390840/
6. Liu, Tongyan, Han, Chencheng, Fang, Panqi, Hu, Zhibin, Yin, Rong. 2022. Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma. In Journal of hematology & oncology, 15, 141. doi:10.1186/s13045-022-01359-4. https://pubmed.ncbi.nlm.nih.gov/36209111/
智鼠故事 
